01 / 01

An experimental gene therapy developed at the Telethon Institute of Genetics and Medicine (TIGEM) in Pozzuoli has shown encouraging clinical results in patients with Usher syndrome type 1B. The first data, presented one year after the start of the clinical trial, show a significant improvement in visual capacity.

Il tuo browser non è più supportato da Microsoft, esegui l'upgrade a Microsoft Edge per visualizzare il sito.